| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/22/2006 | US7094552 Diagnostic test kits |
| 08/22/2006 | US7094549 mass spectroscopy; medical diagnosis/prognosis; kits |
| 08/22/2006 | US7094546 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 08/22/2006 | US7094427 Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 08/22/2006 | US7094410 DNA vaccine against proliferating endothelial cells and methods of use thereof |
| 08/22/2006 | US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating |
| 08/22/2006 | CA2368138C Mechanically stable pharmaceutical presentation form containing liquid or semisolid surface-active substances |
| 08/22/2006 | CA2299503C Anti-first-pass effect compounds |
| 08/22/2006 | CA2267109C Use of conjugated linoleic acid to enhance natural killer lymphocyte function |
| 08/17/2006 | WO2006086600A1 Proteasome inhibitors and methods of using the same |
| 08/17/2006 | WO2006086454A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 08/17/2006 | WO2006085692A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | WO2006085689A1 Anticancer agent to be combined with telomelysin |
| 08/17/2006 | WO2006085688A1 Psychogenic pain therapeutic agent |
| 08/17/2006 | WO2006085687A1 Composition containing dihomo-ϝ-linolenic acid (dgla) as the active ingredient |
| 08/17/2006 | WO2006085685A1 Pyrazole compound |
| 08/17/2006 | WO2006085664A1 Polycation chargeable polymer and use as carrier of nucleic acid |
| 08/17/2006 | WO2006085655A1 Ointment |
| 08/17/2006 | WO2006085562A1 Composition for preventing and/or treating metabolic syndrome and insulin resistance syndrome |
| 08/17/2006 | WO2006085521A1 Medicinal composition for transdermal absorption containing opipid receptor antagonist, method of producing the same and method of promoting the transdermal absorption of the antagonist |
| 08/17/2006 | WO2006085451A1 Method for reconstruction of blood cell from gene-transferred hematopoietic cell |
| 08/17/2006 | WO2006085219A2 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 08/17/2006 | WO2005123068A3 Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor |
| 08/17/2006 | WO2003088904A3 Screening and therapeutic methods for treating circadian rhythm disorders |
| 08/17/2006 | US20060183921 Pharmaceutically active compounds and methods of use |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183794 Drug composition containing nf-kb inhibitor |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183765 Methods of treating cancer using an FPT inhibitor and antineoplastic agents |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/17/2006 | US20060183727 Estrogenic compounds as anti-mitotic agents |
| 08/17/2006 | US20060183695 Methods of increasing endogenous erythropoietin (EPO) |
| 08/17/2006 | US20060183687 Novel therapeutic molecules |
| 08/17/2006 | US20060183674 Compositions and methods for treating diabetes |
| 08/17/2006 | US20060183194 Heregulin variants |
| 08/17/2006 | US20060183191 Synthetic approach to designed chemical structures |
| 08/17/2006 | US20060183160 Novel beta-secretase and modulation of beta-secretase activity |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182817 Steroidal sapogenins and their derivatives for treating Alzheimer's disease |
| 08/17/2006 | US20060182760 Method for protecting living body from external factor and composition therefor |
| 08/17/2006 | US20060182683 Methods for reduced renal uptake of protein conjugates |
| 08/17/2006 | DE102005001252A1 Zusammensetzung zur Behandlung der Apnoe, des Schnarchens und von Schlafstörungen Composition for the treatment of apnea, snoring and sleep disorders |
| 08/17/2006 | CA2599112A1 Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient |
| 08/17/2006 | CA2597541A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | CA2597537A1 Ointment |
| 08/17/2006 | CA2597273A1 Proteasome inhibitors and methods of using the same |
| 08/17/2006 | CA2596422A1 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 08/17/2006 | CA2595495A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 08/16/2006 | EP1690874A2 BMP-12, BMP-13 and tendon-inducing compositions thereof |
| 08/16/2006 | EP1690869A1 Peptide inhibiting angiontensin converting enzyme |
| 08/16/2006 | EP1690864A2 Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling |
| 08/16/2006 | EP1690863A1 Novel condensed imidazole derivative |
| 08/16/2006 | EP1690853A1 W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/16/2006 | EP1690852A1 Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto |
| 08/16/2006 | EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 08/16/2006 | EP1690519A1 Alpha-glucosidase activity inhibitor |
| 08/16/2006 | EP1689416A1 Disinfecting composition and methods of making and using same |
| 08/16/2006 | EP1689397A2 Amelioration of macular degeneration and other ophthalmic diseases |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1497295B1 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 08/16/2006 | EP1487437B1 Use of selective ep4 receptor agonists for the treatment of diseases |
| 08/16/2006 | EP1482948B1 Continuous sulfatase inhibiting progestogen hormone replacement therapy |
| 08/16/2006 | EP1432702B1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1370641B1 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia |
| 08/16/2006 | EP1337247B1 Use of Gaboxadol for the treatment of premenstrual disorder, postnatal depression or postmenopausal related dysphoric disorder |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1276853B1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 08/16/2006 | EP1276471B1 Membrane delivery system |
| 08/16/2006 | EP1272225B1 Lipid-based systems for targeting diagnostic agents |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1227810B8 Treating cancer by increasing intracellular malonyl coa levels |
| 08/16/2006 | EP1196179B1 Hyaluronic acid esters for the treatment of normotrophic scarring of the skin |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1123120B1 Medicinal aerosol formulation |
| 08/16/2006 | EP1084143B1 Purification process for production of mannan-binding lectin and an mbl medicinal product |
| 08/16/2006 | EP1053324B1 Novel cystine knot protein and materials and methods for making it |
| 08/16/2006 | EP1028729B1 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0980362B1 Substituted heterocycles and their use in medicaments |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | EP0861236B2 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 08/16/2006 | EP0809655B1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION |
| 08/16/2006 | EP0784690B1 Complementary adenoviral vector systems and cell lines |
| 08/16/2006 | EP0527917B2 Use of adenosine and adenosine derivatives for anesthesia |
| 08/16/2006 | CN1819833A Hgf production accelerator containing heparin-like oligosaccharide |
| 08/16/2006 | CN1817884A Pyrimidinone derivatives and 3-keto ester |
| 08/16/2006 | CN1817363A Medicine for treating various diseases |
| 08/16/2006 | CN1817163A Formulation of Pueraria Mulberry |
| 08/16/2006 | CN1269958C Zinc finger binding domains for GNN |
| 08/16/2006 | CN1269839C Treatment with anti-ErbB2 antibodies |
| 08/16/2006 | CN1269822C Inhibitors of cruzipain and other cysteine proteases |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269814C Process and intermediates for pyridazinone antidiabetic agents |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |